More recent studies have improved our understanding of inherited ovarian cancer risk beyond BRCA-related HBOC, and have allowed more detailed estimates of ovarian cancer risk for several homologous recombination (HR)-related genes with moderate-penetrance such as BRIP1, RAD51C/D, PALB2, and ATM [6,7]. The gene discussed is PALB2; the disease is ovarian carcinoma.